"Parking lot 6 at UCH will be closed for construction October 26th through November 24th. During this time, please use parking lot 2, garage 3 or our free valet parking services. UCHealth primary care, urgent care, specialty clinics and hospitals are safe and open. Your safety is our top priority while providing you with the highest level of care."

During the past decade, University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP) conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP)" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Academic GI Cancer Consortium (AGICC)" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP)" are "Melanoma" (2 trials), "Respiratory Tract Infection" (2 trials), "Advanced Cancer" (1 trials), "Advanced Cancers" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP)" in a lesser frequency.

Most popular intervention types in "University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP)" are "Drug" (14 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (2 trials), "Palbociclib" (2 trials), "Placebo" (2 trials), "Anti-PD1" (1 trials) and "Anti-VEGF" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP)" are 12 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP)". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP), undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP), 7 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".